Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1999 • 5,659 citations

CpG Motifs in Bacterial DNA and Their Immune Effects

2002 • 2,520 citations

Cancer/testis antigens, gametogenesis and cancer

2005 • 1,541 citations

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1997 • 1,235 citations

CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity

1997 • 1,008 citations

Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization

1999 • 898 citations

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

2002 • 851 citations

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

1998 • 712 citations

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

1993 • 706 citations

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909

2005 • 619 citations

Molecular Basis of Fc Receptor Function

1994 • 523 citations

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

2001 • 500 citations

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

2004 • 446 citations

Toll‐like receptor stimulation as a third signal required for activation of human naive B cells

2006 • 428 citations

Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells

2002 • 355 citations

Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells

2006 • 333 citations

Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.

2003 • 332 citations

Fc receptors are required in passive and active immunity to melanoma

1998 • 322 citations

CpG motifs: the active ingredient in bacterial extracts?

2003 • 280 citations

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

2006 • 279 citations

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

2006 • 274 citations

Cross-presentation: a general mechanism for CTL immunity and tolerance

1998 • 253 citations

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients

2006 • 216 citations

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

2004 • 202 citations

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein.

1995 • 186 citations

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells

2002 • 173 citations

CpG-DNA Aided Cross-Priming by Cross-Presenting B Cells

2004 • 140 citations

Human Immunoglobulin G and Immunoglobulin G Subclasses: Biochemical, Genetic, and Clinical Aspects

1989 • 140 citations

NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

2002 • 115 citations

CpG-A and CpG-B oligonucleotides differentially enhance human peptide–specific primary and memory CD8+ T-cell responses in vitro

2003 • 112 citations

Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations

2002 • 88 citations

CpG Oligodeoxynucleotide and Montanide ISA 51 Adjuvant Combination Enhanced the Protective Efficacy of a Subunit Malaria Vaccine

2004 • 83 citations

Pillars article: two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999. 401: 708-712.

2014 • 56 citations

Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor

1999 • 49 citations

Dominant B cell epitope from NY‐ESO‐1 recognized by sera from a wide spectrum of cancer patients: Implications as a potential biomarker

2004 • 39 citations

IFN-γ enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation

2004 • 36 citations

Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen

2006 • 18 citations

Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses

2005 • 17 citations

A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients

2005 • 10 citations